Treatment Resistant Depression Study - ECT Versus Ketamine
Baylor College of Medicine and the Michael E. DeBakey VA Medical Center are conducting a clinical trial in individuals between the ages of 21-75 to study the comparative effectiveness of ECT versus Ketamine in patients suffering from treatment-resistant depression. The study is sponsored by the Patient-Centered Outcomes Research Institute (PCORI) and is being conducted at several sites nationwide.
If eligible, participants will receive the study treatments and all study-related care at no cost. Compensation will also be provided for time and travel.
All inquiries are confidential. Contact us at (713) 689-9856 or firstname.lastname@example.org.